Cyndi Williams, CEO of diabetes-focused tech start-up Quin, discusses career paths, company culture and her exceptional co-founder.
Cyndi Williams is the co-founder and CEO of Quin, an app designed to help people with diabetes keep track of their insulin.
The app works with data logged into a mobile device, along with continuous glucose monitoring (CGM) devices, to enable people with diabetes to recognise patterns and rely less on trial and error when it comes to insulin administration.
The question that were focused on at Quin is how much insulin a person should take and when, Williams told Siliconrepublic.com. Thats a question that millions of people with insulin-treated diabetes need to answer several times a day, and no one knows the exact answer.
Williams explained that most people with diabetes have to figure out the answer to that question every day, making important healthcare decisions using their own intuition and knowledge of experience.
The goal is to formalise the knowledge of Quin users, with the aim of contributing that data to diabetes research in order to advance personalised medicine for insulin-treated diabetes.
From left: Vanessa Bolosier and Isabella Degen. Image: Quin
We made a mobile app that takes data from existing CGM devices for diabetes, which is a sensor often worn on the arm to measure blood glucose. People also use insulin pens or syringes to inject insulin, and all of our users use an iPhone, Williams said.
We take data off of those devices, we take their activity data from their phone, and we use it to observe and learn how each individual is doing their trial and error on a day-to-day basis as they are going about their lives, and give them advice in the moment they need it, based on their past experience.
One example she gave was ordering a coffee. You may have drank hundreds of lattes in your life and dosed anywhere from zero to five units for lattes. How much should you take for this latte?
Quin would look at how long you slept for last night, how active you have been in the past 24 hours, what insulin you have onboard already, where you are in your menstrual cycle and how you feel in terms of stress.
We look at all of those factors and things that are affecting you, and we go into your past and find the latte decision that is most relevant for you and most closely matches your current situation, then give that to you as the basis for making your decision.
London-based Quin was founded in 2014, but how did Williams end up in the world of diabetes tech?
It was a couple of things, but mainly my interest in Isabella Degen, my co-founder. My background is in chemical engineering and software engineering, but Ive been on the business side of engineering for the last 15 years.
Prior to setting up Quin, Williams worked at Sun Microsystems before becoming a managing director at software and services business ThoughtWorks. This is where she met Degen, also an engineer, whose own diabetes had inspired a potential business idea.
At the time I didnt know anything about diabetes, Williams said. I didnt even know she had diabetes! I just knew how exceptional she was and she was looking for someone to help her set up a business.
Williams added that she was excited to solve a human problem with technology, and that the whole idea tickled the nerve of the engineer within her. Its also a dream to be able to do something that could actually make a material difference to peoples lives.
From left: Cyndi Williams and Isabella Degen. Image: Quin
With an official launch planned for later this year, Quin has been developed behind closed doors for the last two years as part of a research programme with around 100 people who have been providing feedback, ideas and thoughts on the design.
We are a regulated medical device company, Williams said. Every release of our app is a regulated medical device that is released and pushed out to our market. We want to do a human-centred co-creation of a medical device, while also ensuring that what we are doing is safe, will not hurt anyone and will improve the lives of users.
As part of that, we do regular self-reported results from our users and look at three categories of metrics, which are quality of life improvements, medical benefits and behavioural changes that people make.
We have had 76pc of our users reporting that they feel more confident, relaxed and that life with diabetes is easier, from the quality of life point of view. Thats something were very proud of. Its critical as a software product maker that youve got to make a material difference to peoples quality of life.
Aside from tech and engineering, one area of business that Williams is particularly interested in is workplace culture. She spent much of her time in leadership roles at ThoughtWorks coming up with the values, living the values and leading by the values.
What were doing now, our mission is very human-centred and is about making life better for potentially millions of people, she explained. Its really about the values that you put underneath that. For us, our values are quite simple: be excellent, find truth and show love.
The Quin team. Image: Quin
For us, excellence is your interest in collaborating across the areas of the discipline and your ability to draw people in and take people with you on that journey, Williams added.
Finding truth is about the fact that we know so little about diabetes, as well as being willing to throw away our truths when we have to and the problem-solving nature of who we are as people.
The third value is to show love, which is about the space that we live in. Because diabetes is so poorly understood, theres a lot of hurt that happens to people who are living with diabetes. It starts with love for the people we are creating for and working with, but it extends to love for your colleagues.
Although a launch is upcoming, Williams said that the mission of Quin could take 10 years or more. This is hard work certainly the hardest work of my life and the lives of many people who work here. We have to have an unconditional positive regard for each other and really be willing to walk in each others shoes.
To ensure that Quin hires the right people, Williams said that she selects interviewees based on their technical skills as well as their affinity to those values. She added that she asks some pretty pointed questions during the interview process to ensure that new hires share those values.
Its about living those values when were inside and what we do every day and how we behave. It matters. Isabella and I have only ever been in value-based organisations, so if you grow up with it, its sort of second nature.
Want stories like this and more direct to your inbox? Sign up forTech Trends, Silicon Republics weekly digest of need-to-know tech news.
The rest is here:
Cyndi Williams on tech for diabetes and 'showing love' at work - Siliconrepublic.com
- World Diabetes Day 2024 - World Health Organization (WHO) - December 6th, 2024
- The WHO Global Diabetes Compact - December 6th, 2024
- Diabetes - World Health Organization (WHO) - December 6th, 2024
- Kumamoto University researchers discover groundbreaking antidiabetic compound - EurekAlert - December 6th, 2024
- Med's David Kaelber comments on GLP-1 agonists, which provide benefits like managing diabetes and weight loss - The Daily | Case Western Reserve... - December 6th, 2024
- Jordan Chiles Is On a Mission To Raise Awareness for Early Type 1 Diabetes Screening - Verywell Health - December 6th, 2024
- There's A Tasty Food That May Reduce Your Risk Of Developing Type 2 Diabetes, Study Shows - HuffPost - December 6th, 2024
- Empagliflozin Linked to Lower Risk of Diabetic Retinopathy Progression - Medpage Today - December 6th, 2024
- GLP-1 Medications Associated with Reduced Likelihood of Dementia Compared to Other Diabetic Meds - Epic Research - December 6th, 2024
- Sanders Slams Greed That Led to Surge in Obesity, Diabetes in US - The Well News - December 6th, 2024
- Eli Lilly to Expand Facility to Meet Demand for Diabetes, Obesity Treatments - The Wall Street Journal - December 6th, 2024
- New Study Teases Out Chocolate and Diabetes Connection - Medpage Today - December 6th, 2024
- Diabetes tool turned wellness trend: Is a glucose monitor right for you? - KARE11.com - December 6th, 2024
- Reporter doesnt have diabetes but wore a glucose monitor anyway. Here's what she learned - CNN - December 6th, 2024
- Lilly's Zepbound (tirzepatide) superior to Wegovy (semaglutide) in head-to-head trial showing an average weight loss of 20.2% vs. 13.7% - Investors |... - December 6th, 2024
- I dont have diabetes, but I wore a glucose monitor for six weeks. Heres what I learned about food (and anxiety) - CNN - December 6th, 2024
- Higher niacin levels linked to lower cardiovascular risk, but not in those with diabetes - Healio - December 6th, 2024
- This Type Of Chocolate Could Reduce Type 2 Diabetes Risk By 21% - NDTV - December 6th, 2024
- New Study Links Safer BPA Alternatives to Obesity, Diabetes, and Hormone Disruption - SciTechDaily - December 6th, 2024
- Turns Out Dark Chocolate Has a Health Benefit That's Shockingly GreatAnd Totally Unexpected - Well+Good - December 6th, 2024
- Global report on diabetes - World Health Organization (WHO) - October 22nd, 2024
- Ultra-processed food may be particularly harmful for people with diabetes, scientists warn - The Independent - October 22nd, 2024
- New drugs may be able to treat multiple problems beyond diabetes - The Straits Times - October 22nd, 2024
- Best Fruits for Diabetes (and What To Avoid) - Health Essentials - October 22nd, 2024
- Cutting Sugar May Reduce Your Diabetes, Stroke, and Depression Risk - Healthline - October 22nd, 2024
- Can Diabetes Care Teams Improve Patient Outcomes and Value? - Medscape - October 22nd, 2024
- Oral Semaglutide Reduces MACE Risk in People With Type 2 Diabetes and CVD - MD Magazine - October 22nd, 2024
- High expression of CNOT6L contributes to the negative development of type 2 diabetes - Nature.com - October 22nd, 2024
- Recent Advances and Therapeutic Benefits of Glucagon-Like Peptide-1 (GLP-1) Agonists in the Management of Type 2 Diabetes and Associated Metabolic... - October 22nd, 2024
- Dental teams could detect undiagnosed diabetes in more than one million people with new care pathway - Nature.com - October 22nd, 2024
- Groundbreaking Innovations in Diabetes Care: Highlights from the 2024 Diabetes Technology Meeting - Beyond Type 1 - October 22nd, 2024
- COVID-19 linked to type 2 diabetes onset in children - Medical Xpress - October 22nd, 2024
- The effect of adding pancreatin to standard otilinium bromide and simethicone treatment in type 2 diabetes mellitus patients with irritable bowel... - October 22nd, 2024
- Does microdosing Ozempic work? What experts are saying about the diabetes drug also used for weight loss - Medical Xpress - October 22nd, 2024
- The Link between GLP-1 Drugs and Diabetic Retinopathy Is Not So Clear | AAO 2024 - Managed Healthcare Executive - October 22nd, 2024
- The overexpression of human amylin in pancreatic cells facilitate the appearance of amylin aggregates in the kidney contributing to diabetic... - October 22nd, 2024
- RNAO releases updated guidelines for diabetic foot ulcer care - Benefits and Pensions Monitor - October 22nd, 2024
- COVID-19 raises the risk of type 2 diabetes in children, study reveals - News-Medical.Net - October 22nd, 2024
- Semaglutide: What impact does it really have on heart health? - Medical News Today - October 22nd, 2024
- Glucose monitors for diabetes have finally been funded but a chronic workforce shortage will limit the benefits - The Conversation - October 22nd, 2024
- Early vs Late Fast Window: Is One More Effective? - Medscape - September 13th, 2024
- Breakthrough T1D Walk to Cure Type 1 Diabetes - KATU - September 13th, 2024
- Foods That May Increase Kids' Risk of Type 1 Diabetes Revealed - Newsweek - September 13th, 2024
- Beds and Herts patients to be re-tested in diabetes results error - BBC.com - September 13th, 2024
- This common habit increases your diabetes risk by 50%; Heres how to fix it - The Economic Times - September 13th, 2024
- Elevated risk of pre-diabetes and diabetes in people with past history of COVID-19 in northeastern Nigeria - BMC Public Health - September 13th, 2024
- Study links bananas, oats and yoghurt to greater diabetes risk in susceptible children - The Guardian - September 13th, 2024
- Could the Norton research teams studying diabetes and Alzheimer's come up with a cure? - Courier Journal - September 13th, 2024
- Weight loss, better beta-cell function tied to long-term glycemic control with tirzepatide - Healio - September 13th, 2024
- Study finds weekly insulin injections as effective for diabetes as daily shots - UPI News - September 13th, 2024
- Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Heres what the science says - The Conversation - September 13th, 2024
- With once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes - PR Newswire - September 13th, 2024
- Dining with Diabetes workshops offered - The Courier-Express - September 13th, 2024
- Researchers uncover connection between two common diabetes drugs with implications for foot ulcer healing - News-Medical.Net - September 13th, 2024
- The menopause can increase your likelihood of developing heart disease, type 2 diabetes and hypertension but exercise can help lower risk - The... - September 13th, 2024
- Artificial pancreas shows promise in people with type 1 diabetes on kidney dialysis - MSN - September 13th, 2024
- How an Indian executive battled flesh-eating disease and diabetes, and won - South China Morning Post - September 13th, 2024
- India brings early Diabetic Retinopathy detection to the last mile with Artificial Intelligence - PR Newswire - September 13th, 2024
- Why this diabetes drug may be the answer to NASA search for radiation protection - Texas Public Radio - September 13th, 2024
- The National Association of Chain Drug Stores and the American Diabetes Association Promote Nutrition Security and its Role in Preventing and Managing... - September 13th, 2024
- He took up running rather than take diabetes medication. It worked - South China Morning Post - March 18th, 2024
- Eli Lilly cracks down on the use of weight loss drugs Mounjaro and Zepbound for cosmetic reasons instead of for diabetes and obesity - Fortune - January 9th, 2024
- Transforming Corporate Health: Fitterfly's Success in Tackling Diabetes and Weight Issues - Business Standard - January 9th, 2024
- For Those With Diabetes On Medicare Part D, Insulin Is $35...If Its Covered - Forbes - October 27th, 2023
- Biologist Douglas Melton: I was studying frogs until my son was diagnosed with diabetes then I started looking for a cure - EL PAS USA - October 27th, 2023
- Diabetes and Hearing Loss with Concept by Iowa Hearing | Paid Content - Local 5 - weareiowa.com - May 9th, 2023
- COUNTY COLUMN: Learn to Live well with diabetes at The Well - Norman Transcript - May 1st, 2023
- Want to Cut Type 2 Diabetes Risk? This High-fat Food Can Be the Answer, According to New Study - Revyuh - May 1st, 2023
- Diabetes: What It Is, Causes, Symptoms, Treatment & Types - March 13th, 2023
- A number of healthtech startups claim they can reverse Type 2 diabetes. But caveats apply, caution doctors - Economic Times - March 13th, 2023
- Tampa doctor who lost brother to diabetes calls insulin price cut a 'game changer' - ABC Action News Tampa Bay - March 5th, 2023
- New study suggest people previously infected with COVID-19 could have increased risk for diabetes - CBS Los Angeles - February 16th, 2023
- Diabetes Symptoms, Causes, & Treatment | ADA - October 15th, 2022
- A nutritionist with type 1 diabetes shares the top 5 'food swaps' she eats to manage her blood sugar - CNBC - October 15th, 2022
- Diabetes and the gut: How a bacterial protein may impact insulin - Medical News Today - October 15th, 2022
- Milton teen involved in launch of diabetes support program - Milton Daily Standard - October 15th, 2022
- Providers Now Have Free Access to Latest Diabetes Technology in One Place - PR Newswire - October 15th, 2022
- 5 Modifiable Factors in Women with History of Gestational Diabetes Mellitus That Can Reduce the Risk of T2D - Pharmacy Times - October 15th, 2022
- BCMH the stoy of Diabetes and Determination - 921News - October 15th, 2022
- Can skipping a meal lead to diabetes and fat around abdomen? - The Indian Express - October 15th, 2022